Lista de obras -

133 Structural basis for ebolavirus matrix assembly and budding; protein plasticity allows multiple functions.

artículo científico publicado en 2014

A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus

scientific article published on 01 August 2018

A shared structural solution for neutralizing ebolaviruses

artículo científico publicado en 2011

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

artículo científico publicado en 2007

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Characterization of a human H5N1 influenza A virus isolated in 2003.

artículo científico publicado en 2005

Contribution of Sec61α to the life cycle of Ebola virus

artículo científico publicado en 2011

Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression

artículo científico publicado en 2015

DNA Topoisomerase 1 Facilitates the Transcription and Replication of the Ebola Virus Genome ⬇️

artículo científico publicado el 8 de mayo de 2013

Defining the risk of SARS-CoV-2 variants on immune protection

artículo científico publicado en 2022

Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2

artículo científico publicado en 2020

Distinct patterns of SARS-CoV-2 transmission in two nearby communities in Wisconsin, USA

artículo científico publicado en 2020

Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection

scholarly article by Lauren E Williamson et al published 15 April 2019 in Journal of Virology

Ebola Conquers West Africa - More to Come?

artículo científico publicado en 2014

Ebola Virus Stability Under Hospital and Environmental Conditions

artículo científico publicado en 2016

Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome

artículo científico publicado en 2007

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner

artículo científico publicado en 2010

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

artículo científico publicado en 2004

Generation of biologically contained Ebola viruses

artículo científico publicado en 2008

HER2-mediated enhancement of Ebola virus entry

scientific article published on 14 October 2020

Human influenza a viral genes responsible for the restriction of its replication in duck intestine

artículo científico publicado en 2002

Identification of interferon-stimulated genes that attenuate Ebola virus infection

scientific article published on 11 June 2020

Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus

artículo científico publicado en 2015

Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection

artículo científico publicado en 2019

Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection

artículo científico publicado en 2015

MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling

artículo científico publicado en 2017

Mapping SARS-CoV-2 antigenic relationships and serological responses

artículo científico publicado en 2023

Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism

artículo científico publicado en 2012

Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis

artículo científico publicado en 2017

Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence

artículo científico publicado en 2017

Novel modulators of p53-signaling encoded by unknown genes of emerging viruses

artículo científico publicado en 2021

Novel residues in avian influenza virus PB2 protein affect virulence in mammalian hosts

artículo científico publicado en 2014

Plasma lipidome reveals critical illness and recovery from human Ebola virus disease

scientific article published on 11 February 2019

Pseudoparticle neutralization assay for detecting ebola- neutralizing antibodies in biosafety level 2 settings

artículo científico publicado en 2015

Regions in Ebola virus VP24 that are important for nucleocapsid formation

artículo científico publicado en 2007

Replication-deficient ebolavirus as a vaccine candidate

artículo científico publicado en 2009

Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread

artículo científico publicado en 2020

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo

artículo científico publicado en 2020

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

artículo científico publicado en 2020

SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike

scientific article published on 13 September 2020

Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study

artículo científico publicado en 2019

Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle

artículo científico publicado en 2013

Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus

artículo científico publicado en 2012

Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection

artículo científico publicado en 2015

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

artículo científico publicado en 2020

Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection

The Ebolavirus VP24 Protein Blocks Phosphorylation of p38 Mitogen-Activated Protein Kinase ⬇️

artículo científico publicado el 1 de noviembre de 2011

The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection

scholarly article by Peter Halfmann et al published 22 November 2018 in Journal of Infectious Diseases

The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

artículo científico publicado en 2016

The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication

artículo científico publicado en 2013

The landscape of antibody binding in SARS-CoV-2 infection

artículo científico publicado en 2021

The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells

artículo científico publicado en 2013

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck

scientific article published on 17 November 2020

Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates

artículo científico publicado en 2015

Lista de obras de

133 Structural basis for ebolavirus matrix assembly and budding; protein plasticity allows multiple functions.

A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus

A shared structural solution for neutralizing ebolaviruses

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Characterization of a human H5N1 influenza A virus isolated in 2003.

Contribution of Sec61α to the life cycle of Ebola virus

Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression

DNA Topoisomerase 1 Facilitates the Transcription and Replication of the Ebola Virus Genome ⬇️

Defining the risk of SARS-CoV-2 variants on immune protection

Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2

Distinct patterns of SARS-CoV-2 transmission in two nearby communities in Wisconsin, USA

Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection

Ebola Conquers West Africa - More to Come?

Ebola Virus Stability Under Hospital and Environmental Conditions

Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Generation of biologically contained Ebola viruses

HER2-mediated enhancement of Ebola virus entry

Human influenza a viral genes responsible for the restriction of its replication in duck intestine

Identification of interferon-stimulated genes that attenuate Ebola virus infection

Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus

Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection

Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection

MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling

Mapping SARS-CoV-2 antigenic relationships and serological responses

Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism

Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis

Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence

Novel modulators of p53-signaling encoded by unknown genes of emerging viruses

Novel residues in avian influenza virus PB2 protein affect virulence in mammalian hosts

Plasma lipidome reveals critical illness and recovery from human Ebola virus disease

Pseudoparticle neutralization assay for detecting ebola- neutralizing antibodies in biosafety level 2 settings

Regions in Ebola virus VP24 that are important for nucleocapsid formation

Replication-deficient ebolavirus as a vaccine candidate

Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike

Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study

Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle

Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus

Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection

The Ebolavirus VP24 Protein Blocks Phosphorylation of p38 Mitogen-Activated Protein Kinase ⬇️

The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection

The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication

The landscape of antibody binding in SARS-CoV-2 infection

The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck

Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates